- Email: [email protected]
Millipore's revenues rise
NEWS
In Brief Zenon tops list of best 50 ‘Corporate Citizens’ in Canada Zenon Environmental Inc has been ranked for a second time as Canada's top ‘Corporate Citizen’ by Corporate Knights, a business publication that addresses corporate responsibility. Companies were scored across seven categories. The categories are Environment, International Stakeholder Relations/ Human Rights, Product Safety and Business Practices, Community Relations, and Employee Relations/ Diversity in the Workplace, Corporate Governance and Financial Performance. SDTC announces funding for clean technology projects The board of directors of Sustainable Development Technology Canada (SDTC) has approved, in principle, funding for 11 clean technology projects — an investment totalling C$32.4 million. These projects are also supported by an additional investment of C$95.6 million from other private and public sources. One project involves the development of membrane technology that has the potential to reduce the overall cost of ethanol production. It is led by Gen-X Power Corp of Alberta, Calgary. Consortium members are Katzen International Inc, University of Calgary, Virtual Materials Group Inc and Natural Resources Canada. FDA approves medication delivery device A new electronic nebulizer developed by PARI Aerosol Research Institute PARI's, has been approved by the US Food and Drug Administration (FDA). eFlow is a small, silent, aerosol device that takes liquid medications and generates a dense aerosol that can be inhaled into the lungs. At the core of the device is a stainless steel membrane that contains 4000 laser drilled holes. Laser drilling provides the flexibility to customize particle size, to ensure reproducibility, and maintain a high output rate with smaller particles. The perforated membrane is vibrated at a high frequency in a resonant ‘bending’ mode which yields a high output rate for particles.
4
NSF International, The Public Health and Safety Company, is a not-for-profit, non-governmental organization, that develops standards, certifies products, and is involved in education and risk-management for public health and safety. Contact: Watts Premier Inc, 1725 W. Williams Drive, C-20, Phoenix, AZ 85027, USA. Tel: +1 623 931 1977, Fax: +1 623 931 0191.
Improved protein detection Vivascience AG of Hanover, Germany, has introduced a new Vivapure Anti-HSA Kit for removing albumin from human serum. It is based on unique Anti-HSA antibody fragments coupled to cross-linked agarose for achieving high albumin binding capacities. The company claims that in contrast to traditional dye-based ligands, specific removal of over 95% human albumin from a human sample is achieved without including significant amounts of other serum or plasma proteins. According to Vivascience, this procedure improves the resolution and detection of lower abundance sample proteins by electrophoresis, chromatography and mass spectrometry. The Vivapure Anti-HSA Kit for human albumin depletion contains Anti-HSA affinity-resin, centrifugal columns (which can be filled individually with the required amount of Anti-HSA resin), micro-centrifuge tubes and binding buffer for preparing 12 serum samples. The spin column format allows a single sample to be processed in 20 minutes, says the company. Vivascience AG is a subsidiary of Sartorius AG, which is based in Goettingen, Germany. Originally founded as Vivascience Ltd in Stonehouse, UK, the biotechnology company employs 80 people at four subsidiaries in Germany, USA, UK, and France. Contact: Vivascience AG, Feodor-Lynen-Strasse 21, 30625 Hannover, Germany. Tel: +49 511 524 8750, Fax: +49 511 524 87519, Email: [email protected].
Polypore International seeks IPO Polypore International Inc of Charlotte, North Carolina, USA, is planning to raise up to US$345 million through an initial public offering (IPO) of common stock. The company has filed for an IPO with the US Securities and Exchange Commission, and says that net proceeds will be used to reduce debt, including part of the senior subordinated notes issued by subsidiary Polypore Inc. The company intends to list its stock on the New York Stock Exchange under the symbol ‘PLY’. Polypore makes polymer-based membranes used in separation and filtration processes. The company, which employs 2000 worldwide, markets its products to the power storage, health-care, electronics and speciality technology industries. In fiscal 2003, Polypore generated revenue totalling US$441.1 million and net income of US$45.3 million. During December 1999, the company acquired the Celgard lithium battery separator and separation membrane business of Celanese AG. To expand its presence in the health-care and speciality filtration markets, it acquired German corporation Membrana GmbH in February 2002. The company's international operations are based in Wuppertal, Germany. Contact: Polypore International Inc, 13800 S. Lakes Drive, Charlotte, NC 28273, USA. Tel: +1 704 588 5310, Fax: +1 704 587 8585.
GE distributes Proton Energy Systems' products Proton Energy Systems Inc, a subsidiary of Distributed Energy Systems Corp, and a manufacturer of the membrane-based Hogen on-site hydrogen generator, has signed a distribution agreement with GE Supply, a business unit of General Electric Co.
The 36-month agreement appoints GE as a non-exclusive distributor of Proton's products for the electric power-generating industry throughout the world, excluding certain European countries. Proton Energy Systems Inc designs, develops and manufactures proton exchange membrane (PEM), electrochemical products which it employs in hydrogengenerating devices and in regenerative fuel cell systems that function as power-generating and energy storage devices. The Hogen hydrogen generators produce hydrogen from electricity and water in a clean and efficient process using its proprietary PEM technology. Contact: Proton Energy Systems Inc, 10 Technology Drive, Wallingford, CT 06492, USA. Tel: +1 203 678 2000, Fax: +1 203 949 8016, Email: [email protected].
Millipore's revenues rise Millipore Corp of Billerica, Massachusetts, USA, posted strong results for its second quarter ended 30 June 2004. The company's sales rose by 14% to US$225 million, compared with the equivalent period a year earlier. In local currency terms, revenue growth was 11%. Second-quarter earnings were US$0.57 per share, up 24% from US$0.46 per share in the second quarter of 2003. Fran Lunger, Millipore's Chief Executive Officer, said: "Our second quarter matched our strong first-quarter performance, with growth in all geographic regions and markets." Of particular note, he says, is the biotechnology market revenue growth of 21% in local currency terms. Life sciences grew 9% in local currency terms, compared with the corresponding period of 2003, while other bioscience achieved 5% growth. Contact: Millipore Corp, 290 Concord Road, Billerica, MA 01821, USA. Tel: +1 978 715 4321, Fax: +1 781 533 3110.
Membrane Technology August 2004
In Brief Zenon tops list of best 50 ‘Corporate Citizens’ in Canada Zenon Environmental Inc has been ranked for a second time as Canada's top ‘Corporate Citizen’ by Corporate Knights, a business publication that addresses corporate responsibility. Companies were scored across seven categories. The categories are Environment, International Stakeholder Relations/ Human Rights, Product Safety and Business Practices, Community Relations, and Employee Relations/ Diversity in the Workplace, Corporate Governance and Financial Performance. SDTC announces funding for clean technology projects The board of directors of Sustainable Development Technology Canada (SDTC) has approved, in principle, funding for 11 clean technology projects — an investment totalling C$32.4 million. These projects are also supported by an additional investment of C$95.6 million from other private and public sources. One project involves the development of membrane technology that has the potential to reduce the overall cost of ethanol production. It is led by Gen-X Power Corp of Alberta, Calgary. Consortium members are Katzen International Inc, University of Calgary, Virtual Materials Group Inc and Natural Resources Canada. FDA approves medication delivery device A new electronic nebulizer developed by PARI Aerosol Research Institute PARI's, has been approved by the US Food and Drug Administration (FDA). eFlow is a small, silent, aerosol device that takes liquid medications and generates a dense aerosol that can be inhaled into the lungs. At the core of the device is a stainless steel membrane that contains 4000 laser drilled holes. Laser drilling provides the flexibility to customize particle size, to ensure reproducibility, and maintain a high output rate with smaller particles. The perforated membrane is vibrated at a high frequency in a resonant ‘bending’ mode which yields a high output rate for particles.
4
NSF International, The Public Health and Safety Company, is a not-for-profit, non-governmental organization, that develops standards, certifies products, and is involved in education and risk-management for public health and safety. Contact: Watts Premier Inc, 1725 W. Williams Drive, C-20, Phoenix, AZ 85027, USA. Tel: +1 623 931 1977, Fax: +1 623 931 0191.
Improved protein detection Vivascience AG of Hanover, Germany, has introduced a new Vivapure Anti-HSA Kit for removing albumin from human serum. It is based on unique Anti-HSA antibody fragments coupled to cross-linked agarose for achieving high albumin binding capacities. The company claims that in contrast to traditional dye-based ligands, specific removal of over 95% human albumin from a human sample is achieved without including significant amounts of other serum or plasma proteins. According to Vivascience, this procedure improves the resolution and detection of lower abundance sample proteins by electrophoresis, chromatography and mass spectrometry. The Vivapure Anti-HSA Kit for human albumin depletion contains Anti-HSA affinity-resin, centrifugal columns (which can be filled individually with the required amount of Anti-HSA resin), micro-centrifuge tubes and binding buffer for preparing 12 serum samples. The spin column format allows a single sample to be processed in 20 minutes, says the company. Vivascience AG is a subsidiary of Sartorius AG, which is based in Goettingen, Germany. Originally founded as Vivascience Ltd in Stonehouse, UK, the biotechnology company employs 80 people at four subsidiaries in Germany, USA, UK, and France. Contact: Vivascience AG, Feodor-Lynen-Strasse 21, 30625 Hannover, Germany. Tel: +49 511 524 8750, Fax: +49 511 524 87519, Email: [email protected].
Polypore International seeks IPO Polypore International Inc of Charlotte, North Carolina, USA, is planning to raise up to US$345 million through an initial public offering (IPO) of common stock. The company has filed for an IPO with the US Securities and Exchange Commission, and says that net proceeds will be used to reduce debt, including part of the senior subordinated notes issued by subsidiary Polypore Inc. The company intends to list its stock on the New York Stock Exchange under the symbol ‘PLY’. Polypore makes polymer-based membranes used in separation and filtration processes. The company, which employs 2000 worldwide, markets its products to the power storage, health-care, electronics and speciality technology industries. In fiscal 2003, Polypore generated revenue totalling US$441.1 million and net income of US$45.3 million. During December 1999, the company acquired the Celgard lithium battery separator and separation membrane business of Celanese AG. To expand its presence in the health-care and speciality filtration markets, it acquired German corporation Membrana GmbH in February 2002. The company's international operations are based in Wuppertal, Germany. Contact: Polypore International Inc, 13800 S. Lakes Drive, Charlotte, NC 28273, USA. Tel: +1 704 588 5310, Fax: +1 704 587 8585.
GE distributes Proton Energy Systems' products Proton Energy Systems Inc, a subsidiary of Distributed Energy Systems Corp, and a manufacturer of the membrane-based Hogen on-site hydrogen generator, has signed a distribution agreement with GE Supply, a business unit of General Electric Co.
The 36-month agreement appoints GE as a non-exclusive distributor of Proton's products for the electric power-generating industry throughout the world, excluding certain European countries. Proton Energy Systems Inc designs, develops and manufactures proton exchange membrane (PEM), electrochemical products which it employs in hydrogengenerating devices and in regenerative fuel cell systems that function as power-generating and energy storage devices. The Hogen hydrogen generators produce hydrogen from electricity and water in a clean and efficient process using its proprietary PEM technology. Contact: Proton Energy Systems Inc, 10 Technology Drive, Wallingford, CT 06492, USA. Tel: +1 203 678 2000, Fax: +1 203 949 8016, Email: [email protected].
Millipore's revenues rise Millipore Corp of Billerica, Massachusetts, USA, posted strong results for its second quarter ended 30 June 2004. The company's sales rose by 14% to US$225 million, compared with the equivalent period a year earlier. In local currency terms, revenue growth was 11%. Second-quarter earnings were US$0.57 per share, up 24% from US$0.46 per share in the second quarter of 2003. Fran Lunger, Millipore's Chief Executive Officer, said: "Our second quarter matched our strong first-quarter performance, with growth in all geographic regions and markets." Of particular note, he says, is the biotechnology market revenue growth of 21% in local currency terms. Life sciences grew 9% in local currency terms, compared with the corresponding period of 2003, while other bioscience achieved 5% growth. Contact: Millipore Corp, 290 Concord Road, Billerica, MA 01821, USA. Tel: +1 978 715 4321, Fax: +1 781 533 3110.
Membrane Technology August 2004